Here are five things to know about Mr. Snodgrass:
1. Mr. Snodgrass has been with the company since 2020, previously serving as AmSurg’s president.
2. From April 2013 to September 2020, he served as president and CEO of Fresenius Vascular Care & National Cardiology Partners.
3. Under his leadership, Fresnius’ vascular network “transformed from an office-based outpatient business to an ambulatory surgical care company,” according to AmSurg’s website.
4. He has also served in executive roles at inVentiv Health, Merck Research Laboratories and Merck, according to his LinkedIn profile.
5. AmSurg has more than 250 surgery centers in 34 states and Washington, D.C.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.